文献速递心境障碍焦虑、强迫与应激相关障碍

臂旁核PACAP激活杏仁核内体ERK信号调控疼痛情绪成分

Parabrachial Pituitary Adenylate Cyclase-Activating Polypeptide Activation of Amygdala Endosomal Extracellular Signal-Regulated Kinase Signaling Regulates the Emotional Component of Pain.
PubMed 文献 · Biol Psychiatry · 2016-08-29

该研究利用大鼠坐骨神经慢性压迫损伤模型,发现慢性神经病理性疼痛上调脊髓-臂旁核-杏仁核通路中PACAP表达,并增强中央杏仁核PACAP免疫反应性、ERK磷酸化及c-Fos激活,伴随焦虑样行为与痛觉过敏。中央杏仁核注射PACAP受体拮抗剂或内体信号抑制剂可减轻上述行为反应。

要点

  • 慢性神经病理性疼痛上调脊髓-臂旁核-杏仁核通路PACAP表达。
  • 中央杏仁核PACAP受体拮抗可阻断疼痛相关行为反应。
  • 抑制内体PACAP受体ERK信号减轻PACAP诱导的神经元激活。

核心结论

  • 慢性疼痛诱导的臂旁核-杏仁核PACAP神经可塑性与信号传导影响中央杏仁核应激与痛觉相关适应不良反应。
  • 即使损伤进展期间,PACAP受体拮抗也可改善上述反应。

研究设计与样本

  • 采用啮齿类动物坐骨神经慢性压迫损伤模型,每组每实验n=5-8。
  • 使用免疫细胞化学、药物治疗和行为测试技术评估PACAP可塑性与信号传导。

主要发现

  • 慢性神经病理性疼痛增加脊髓-臂旁核-杏仁核通路多个层级的PACAP表达。
  • 慢性压迫损伤双侧增加中央杏仁核PACAP免疫反应性、ERK磷酸化及c-Fos激活,并伴焦虑样行为和痛觉过敏。
  • 中央杏仁核急性注射PACAP受体拮抗剂PACAP(6-38)阻断慢性压迫损伤诱导的行为反应。
  • 预处理MAPK酶抑制剂或内吞抑制剂阻断内体PACAP受体ERK信号,减轻PACAP诱导的中央杏仁核神经元激活和痛觉反应。

关键数值与推荐

  • 中央杏仁核注射PACAP受体拮抗剂PACAP(6-38)可阻断慢性压迫损伤诱导的行为反应。
  • 抑制内体PACAP受体ERK信号可减弱PACAP诱导的中央杏仁核神经元激活和痛觉反应。

临床怎么用

  • PACAP通路可能为应激与慢性疼痛在杏仁核交汇的机制提供靶点。
  • PACAP受体拮抗可能改善慢性疼痛相关的焦虑样行为和痛觉过敏。

局限性

  • 研究采用啮齿类动物模型,结果外推至人类需谨慎。
  • 样本量较小(每组每实验n=5-8)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic pain and stress-related psychopathologies, such as depression and anxiety-associated abnormalities, are mutually reinforcing; however, the neuronal circuits and mechanisms that underlie this reinforcement are still not well understood. Pituitary adenylate cyclase-activating polypeptide (PACAP; Adcyap1) and its cognate PAC1 receptor (Adcyap1r1) are expressed in peripheral nociceptive pathways, participate in anxiety-related responses and have been have been linked to posttraumatic stress disorder and other mental health afflictions. METHODS: Using immunocytochemistry, pharmacological treatments and behavioral testing techniques, we have used a rodent partial sciatic nerve chronic constriction injury model (n = 5-8 per group per experiment) to evaluate PACAP plasticity and signaling in nociceptive and stress-related behaviors. RESULTS: We show that chronic neuropathic pain increases PACAP expression at multiple tiers along the spinoparabrachioamygdaloid tract. Furthermore, chronic constriction injury bilaterally augments nociceptive amygdala (in the central nucleus of the amygdala [CeA]) PACAP immunoreactivity, extracellular signal-regulated kinase phosphorylation, and c-Fos activation, in parallel with heightened anxiety-like behavior and nociceptive hypersensitivity. Acute CeA infusions with the PACAP receptor antagonist PACAP(6-38) blocked chronic constriction injury-induced behavioral responses. Additionally, pretreatments with inhibitors of mitogen-activated protein kinase enzymes or endocytosis to block endosomal PACAP receptor extracellular signal-regulated kinase signaling attenuated PACAP-induced CeA neuronal activation and nociceptive responses. CONCLUSIONS: Our data suggest that chronic pain-induced PACAP neuroplasticity and signaling in spinoparabrachioamygdaloid projections have an impact on CeA stress- and nociception-associated maladaptive responses, which can be ameliorated upon receptor antagonism even during injury progression. Thus, the PACAP pathway provides for an important mechanism underlying the intersection of stress and chronic pain pathways via the amygdala.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Missig G, Mei L, Vizzard MA, et al. Parabrachial Pituitary Adenylate Cyclase-Activating Polypeptide Activation of Amygdala Endosomal Extracellular Signal-Regulated Kinase Signaling Regulates the Emotional Component of Pain. Biol Psychiatry. 2016. PMID: 28057459. doi:10.1016/j.biopsych.2016.08.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。